Robert Viafora
About Robert Viafora
Robert Viafora is the US Immunoscience Sales Lead at Bristol Myers Squibb, with over a decade of experience at the company and a strong background in market access and immunoscience sales.
Title and Current Role
Robert Viafora serves as the US Immunoscience Sales Lead and National Sales Director at Bristol-Myers Squibb in New York, New York. In this capacity, he is responsible for leading the immunoscience sales team across the United States, combining strategic oversight with operational execution to drive sales performance in this specialized sector.
Company Tenure at Bristol-Myers Squibb
Robert Viafora has been with Bristol-Myers Squibb for over a decade, having joined the company in 2009. During his tenure, he has held various leadership roles, including Executive Director of Market Access Sales. His long-term commitment to the company underscores his extensive experience and deep understanding of the pharmaceutical and immunoscience sectors.
Previous Experience in Market Access Sales
Before transitioning to his current role, Robert Viafora was the Executive Director of Market Access Sales at Bristol-Myers Squibb from 2009 to 2014. In this role, he was responsible for leading market access strategies and managing sales teams, contributing significantly to the company's sales initiatives and market penetration strategies over a five-year period.
Educational Background
Robert Viafora has a robust educational foundation, having earned a Bachelor of Science from Rutgers University. He further advanced his academic credentials with a Master of Business Administration from Fairleigh Dickinson University. This combination of scientific and business education equips him with a unique perspective that enhances his strategic capabilities in the pharmaceutical sales arena.
Expertise in Immunoscience Sales
In his current role as US Immunoscience Sales Lead, Robert Viafora leverages his deep knowledge of the US immunoscience market. His expertise is instrumental in guiding the sales team, developing strategic initiatives, and driving performance. His comprehensive understanding of the sector allows him to navigate the complexities of immunoscience sales effectively, ensuring the company's continued success in this specialized market.